RxDoctor Payments Data

Frances Hernandez, MD

Dermatology · San Juan, PRNPI 1073716122

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.4% of the total across 223 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations.

$4,582in general payments, 2019–2025

Across 223 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$660
  • Novartis$508
  • Johnson & Johnson$417
  • Sanofi$367
  • Lilly USA, LLC$352
  • AbbVie$330
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$4,36995%
  • Education$2135%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,582 in reported general payments places this provider in the 75th percentile of 108 dermatology providers in Puerto Rico.

See all dermatology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$677,423
Medicare patients
1,522
Services billed
9,643

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole297$4,894
Fluorouracil78$4,813
Betamethasone Dipropionate152$4,801
Clobetasol Propionate96$3,679
Metronidazole56$2,897
Ciclopirox65$1,797
Triamcinolone Acetonide155$1,762
Imiquimod30$766
Doxycycline Hyclate51$755
Alclometasone Dipropionate16$562
Minocycline Hcl12$541
Finasteride27$483
Nystatin26$415
Mupirocin59$388
Betamethasone Valerate20$383

Paid to pharmacies, not to this prescriber.

Other dermatology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →